Penicilloyl-Polylysine Stability and Clinical Use Over Time

Penicilloyl-Polylysine Stability and Clinical Use Over Time


Eric Macy, MD; CK Lin, PhD; Bruce Goldberg, MD, PhD

Fall 2007 - Volume 11 Number 4


Background: The major penicillin skin test reagent, penicilloyl-polylysine, has not been commercially available since October 2004. The minimal concentration of penicilloyl-polylysine necessary for safe penicillin skin testing has not been determined.

Methods: Penicillin skin testing was performed on 596 individuals between October 2004 and October 2006 using out-of-date commercially produced penicilloyl-polylysine as part of a complete panel of reagents. The concentration of active penicilloyl-polylysine was measured. Outcomes were compared with those for 921 individuals tested between October 2002 and September 2004 using in-date commercially produced penicilloyl-polylysine.

Results: There was no significant difference in the fraction of patients who had positive skin test results using indate (5.1%) versus out-of-date (4.7%) penicilloyl-polylysine . There were four mild but no serious adverse reactions in the patients tested with the outdated reagent who were then challenged with oral penicillin class antibiotics.

Conclusion: Penicillin skin testing can be safely done using penicilloyl-polylysine down to a concentration of 4.29 × 10-5 M.

The Permanente Journal

Sponsored by the eight Permanente Medical Groups, The Permanente Journal advances knowledge in scientific research, clinical medicine, and innovative health care delivery.

Reprint Permissions

The Permanente Journal welcomes requests for reprints and reproduction. Use of any and all material published in The Permanente Journal is copyrighted and protected.

The Permanente Press

The Permanente Press publishes The Permanente Journal and books related to healthcare. Journal subscriptions are entered for the calendar year. Advance payment in US dollars is required.

ISSN 1552-5775 Copyright © 2018

The Permanente Press. All Rights Reserved.